Literature DB >> 18667144

Understanding the pathophysiology of postpartum depression: implications for the development of novel treatments.

Charles B Nemeroff1.   

Abstract

Depression during pregnancy and in the postpartum period is common, devastating to mothers and their offspring, and poorly understood in terms of pathophysiology. In this issue of Neuron, Maguire and Mody provide evidence for a role for aberrant neurosteroid regulation of the GABA(A) receptor subunit in the etiology of postpartum depression, presaging elucidation of the pathophysiology and development of treatments of this depression endophenotype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18667144     DOI: 10.1016/j.neuron.2008.07.015

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  14 in total

Review 1.  Neurosteroids: endogenous role in the human brain and therapeutic potentials.

Authors:  Doodipala Samba Reddy
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

2.  Adolescents' Depressive Symptom Experience Mediates the Impact of Long-Term Exposure to Maternal Depression Symptoms on Adolescents' Body Mass Index.

Authors:  Amber R Cordola Hsu; Zhongzheng Niu; Xiaomeng Lei; Emily Kiresich; Yawen Li; Wei-Chin Hwang; Bin Xie
Journal:  Ann Behav Med       Date:  2020-06-12

Review 3.  Hypothalamic-pituitary-adrenal axis function during perinatal depression.

Authors:  Phillipe Leff Gelman; Mónica Flores-Ramos; Margarita López-Martínez; Carlos Cruz Fuentes; Juan Pablo Reyes Grajeda
Journal:  Neurosci Bull       Date:  2015-03-02       Impact factor: 5.203

Review 4.  Tolerance to allopregnanolone with focus on the GABA-A receptor.

Authors:  Sahruh Turkmen; Torbjorn Backstrom; Goran Wahlstrom; Lotta Andreen; Inga-Maj Johansson
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

Review 5.  Neurosteroid biosynthesis down-regulation and changes in GABAA receptor subunit composition: a biomarker axis in stress-induced cognitive and emotional impairment.

Authors:  Andrea Locci; Graziano Pinna
Journal:  Br J Pharmacol       Date:  2017-06-14       Impact factor: 8.739

6.  Prenatal beta-endorphin as an early predictor of postpartum depressive symptoms in euthymic women.

Authors:  Ilona S Yim; Laura M Glynn; Christine Dunkel Schetter; Calvin J Hobel; Aleksandra Chicz-Demet; Curt A Sandman
Journal:  J Affect Disord       Date:  2010-01-03       Impact factor: 4.839

7.  Maternal postpartum distress and childhood overweight.

Authors:  Teresa A Ajslev; Camilla S Andersen; Katja G Ingstrup; Ellen A Nohr; Thorkild I A Sørensen
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

Review 8.  Modeling postpartum depression in rats: theoretic and methodological issues.

Authors:  Ming Li; Shinn-Yi Chou
Journal:  Dongwuxue Yanjiu       Date:  2016-07-18

9.  Maternal depressive symptoms and the risk of overweight in their children.

Authors:  Liang Wang; James L Anderson; William T Dalton Iii; Tiejian Wu; Xianchen Liu; Shimin Zheng; Xuefeng Liu
Journal:  Matern Child Health J       Date:  2013-07

Review 10.  Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women.

Authors:  Doodipala Samba Reddy
Journal:  J Neuroendocrinol       Date:  2021-09-10       Impact factor: 3.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.